Gain a recognized and traceable certificate after completing the course :
All our certificates are unique, authentic, CPD/CEU accredited, and FDA 21 CFR PART 11 compliant. Certificates validity can be checked online through our certificate online checker.
Clinical Trials Phase I Training: From First-in-Human Design to Safe Dose Escalation
Phase I is where a clinical program is de-risked or derailed. A single dose-setting error can halt a compound indefinitely and cost a sponsor years of development. This certified online learning path for Phase 1 clinical trials, developed under the expert guidance of Dr. Patricia Kay, equips clinical research professionals with the scientific, regulatory, and operational knowledge to design and execute safe, compliant first-in-human studies that meet ICH-GCP E6(R3) and FDA expectations.
Why Choose This Learning Path?
What You’ll Be Able to Do
Who Should Enroll?
Whether you are a clinical research associate, study manager, clinical pharmacologist, or regulatory professional preparing to work on first-in-human studies, this path was designed for you. It is equally valuable for pharmaceutical, biotech, and CRO teams building Phase I capabilities or onboarding clinical staff into early-phase programs.
Lead the Most Critical Phase of Clinical Development
GxP Training delivers certified, employer-recognized training to life sciences professionals worldwide. In an era where a single Phase I failure can delay an entire program by years, first-in-human competency isn’t optional. It is your career foundation. Enroll today and build the skills first-in-human trials demand.
